TherapeuticsMD Inc expected to post a loss of $4.00 a share - Earnings Preview

TherapeuticsMD

13/05/2022 22:52

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a fall
in quarterly revenue when it reports  results on May 16. 
    * The Boca Raton Florida-based  company is expected to
report  a
9.6% decrease in revenue to $17.955 million from $19.87 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TherapeuticsMD Inc
is for
a loss of $4.00 per share. For the same quarter last year, the
company reported a loss of $5.50 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months. ​
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $63​, above​ its last closing price of $2.98. ​​​

This summary was machine generated May 13 at 21:52 GMT.  All
figures in US dollars  unless otherwise stated